Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for GENSCRIPT BIO?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2016–2025
Financial statements are reported in USD, while share price and market cap are quoted in HKD.
Key Multi-Year Facts
- Revenue moved from $114.7M in FY2016 to $959.5M in FY2025 (9-year CAGR +26.6%).
- Net income was negative in FY2019, FY2020, FY2021, FY2022, FY2023, FY2025.
- Operating cash flow was below half of net income in FY2024.
Latest 5 Fiscal Years
| Fiscal Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue (USD B) | 0.49 | 0.63 | 0.56 | 0.59 | 0.96 |
| YoY | 25.4% | 27.7% | -10.4% | 6.1% | 61.4% |
| Net Income (USD B) | -0.36 | -0.23 | -0.10 | 2.96 | -0.53 |
| YoY | — | — | — | — | -118.0% |
| Operating Cash Flow (USD B) | -0.87 | -0.84 | -2.03 | 0.54 | 2.29 |
| ROE | -36.8% | -22.1% | -8.0% | 103.7% | -12.9% |
| Gross Margin | 57.6% | 48.6% | 48.3% | 45.8% | 57.7% |
| Net Margin | -73.2% | -36.3% | -17.0% | 498.2% | -55.5% |
| Debt-to-Assets | 37.9% | 46.5% | 39.6% | 18.1% | 18.3% |
Show all 10 fiscal years
| Fiscal Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD B) | 0.11 | 0.15 | 0.23 | 0.27 | 0.39 | 0.49 | 0.63 | 0.56 | 0.59 | 0.96 |
| YoY | — | 33.0% | 51.3% | 18.3% | 43.0% | 25.4% | 27.7% | -10.4% | 6.1% | 61.4% |
| Net Income (USD B) | 0.03 | 0.03 | 0.02 | -0.10 | -0.20 | -0.36 | -0.23 | -0.10 | 2.96 | -0.53 |
| YoY | — | -0.2% | -18.8% | -556.8% | — | — | — | — | — | -118.0% |
| Operating Cash Flow (USD B) | 0.23 | 0.14 | 2.11 | -0.21 | -0.99 | -0.87 | -0.84 | -2.03 | 0.54 | 2.29 |
| ROE | 14.7% | 13.2% | 6.1% | -22.5% | -31.9% | -36.8% | -22.1% | -8.0% | 103.7% | -12.9% |
| Gross Margin | 66.4% | 68.5% | 68.6% | 66.0% | 65.5% | 57.6% | 48.6% | 48.3% | 45.8% | 57.7% |
| Net Margin | 22.8% | 17.1% | 9.2% | -35.5% | -52.4% | -73.2% | -36.3% | -17.0% | 498.2% | -55.5% |
| Debt-to-Assets | 18.6% | 54.7% | 46.2% | 58.1% | 43.7% | 37.9% | 46.5% | 39.6% | 18.1% | 18.3% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-05
Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).
Items Flagged for Review
- Alert
-
Watch
Net LossesGoing Concern
FY2025 (2025-12-31) $-0.53B, FY2024 (2024-12-31) $2.96B
FY2025 (ended 2025-12-31)
-
Watch
Profit WarningMaterial Events
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
Dividends
No dividends paid over the trailing 12 months.
Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.
More data: All research reports · Sector leaders · Market hours & holidays.
Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.